產(chǎn)品分類
Phospholipids
PEG Derivatives
Block Copolymers
Gold Nanoparticles
Fe3O4 Magnetic nano
Fluorescent dyes
Protein Crosslinkers
Monodispersed PEGs
Click chemistry
Medicinal polymer
APIs cancer
Fluorescence quantum dot
MRI imaging
Microspheres
PROTAC技術(shù)
semiconductor
Synthetic chemistry
Nano drug delivery
Others
快速訂購(gòu)
31952518
  • 029-86354885
  • 18392009562
Home > Products > APIs cancer> Hot APIs cancer> Orteronel; TAK-700,CAS566939-85-3
Orteronel; TAK-700,CAS566939-85-3
Catalog # Pkg Size Price Quantity Shopping Cart
R-SX-510 1 ￥ 1
加入購(gòu)物車
結(jié)構(gòu)式
外觀 N/A
分子量 307.34648
溶解度 N/A
CAS號(hào) 566939-85-3
質(zhì)量控制 N/A
儲(chǔ)存條件 N/A
保存時(shí)間 N/A
其他信息 價(jià)格1，就是價(jià)格現(xiàn)詢
Orteronel(TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer.西安瑞禧生物提供各種抑制劑材料。
親，說(shuō)點(diǎn)什么吧，您的評(píng)價(jià)對(duì)其它買家很有幫助哦~
“好評(píng)，中評(píng)，差評(píng)”請(qǐng)?zhí)顚?xiě)其一哦~
您的昵稱

合作品牌
?
庫(kù)存查詢